Ann Childress

16PUBLICATIONS
17CO-AUTHORS
Adolescent healthChild and adolescent developmentTraditional Chinese medicine and treatmentsMajor global burdens of diseaseToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 24, 2026
Clinically Meaningful Within-Patient Change in Core Attention-Deficit/Hyperactivity Disorder Symptoms in Children and Adolescents Treated With Centanafadine: Results From Two Phase 3 Randomized Clinical Trials.

|Feb 27, 2025
Viloxazine Extended-Release Administered With Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Phase 4, Open-Label Trial.

Ann Childress, Kobby Asubonteng, Georgette Cox

|Feb 19, 2025
Safety and Efficacy of Brexpiprazole in the Treatment of Irritability Associated with Autism Spectrum Disorder: An 8-Week, Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial and 26-Week Open-Label Extension in Children and Adolescents.

Caroline Ward, Ann Childress, Krista Martinko

|Oct 07, 2024
Quality of Life and Outcomes Associated with Adverse Effects in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder and Their Parents/Caregivers.

Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle

|May 21, 2024
Recent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulants.

Ann Childress

|Apr 30, 2024
From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care.

Raman Baweja, Stephen V Faraone, Ann C Childress

Pageof 3

Frequent Collaborators

2 joint publications

Andrew J Cutler

1 joint publications

Lewis Cuthbertson

1 joint publications

Payal Naik

1 joint publications

Raman Baweja